Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Letter by McEvoy regarding article, "Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both".

McEvoy JW.

Circulation. 2011 May 10;123(18):e585; author reply e586-7. doi: 10.1161/CIRCULATIONAHA.110.983569. No abstract available.

2.

Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.

Pouleur AC, Barkoudah E, Uno H, Skali H, Finn PV, Zelenkofske SL, Belenkov YN, Mareev V, Velazquez EJ, Rouleau JL, Maggioni AP, Køber L, Califf RM, McMurray JJ, Pfeffer MA, Solomon SD; VALIANT Investigators.

Circulation. 2010 Aug 10;122(6):597-602. doi: 10.1161/CIRCULATIONAHA.110.940619. Epub 2010 Jul 26.

3.

Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both.

Solomon SD, Zelenkofske S, McMurray JJ, Finn PV, Velazquez E, Ertl G, Harsanyi A, Rouleau JL, Maggioni A, Kober L, White H, Van de Werf F, Pieper K, Califf RM, Pfeffer MA; Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators.

N Engl J Med. 2005 Jun 23;352(25):2581-8. Erratum in: N Engl J Med. 2005 Aug 18;353(7):744.

4.

Sudden cardiovascular death following myocardial infarction: the importance of left ventricular systolic dysfunction and congestive heart failure.

Abildstrom SZ, Ottesen MM, Rask-Madsen C, Andersen PK, Rosthøj S, Torp-Pedersen C, Køber L.

Int J Cardiol. 2005 Sep 30;104(2):184-9.

PMID:
16168812
5.

Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.

Kuch M, Janiszewski M, Mamcarz A, Cudnoch-Jedrzejewska A, Dłuzniewski M.

Med Sci Monit. 2009 Jun;15(6):PH40-8.

PMID:
19478711
6.
7.

Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials.

Farré J, Romero J, Rubio JM, Ayala R, Castro-Dorticós J.

Am J Cardiol. 1999 Mar 11;83(5B):55D-63D.

PMID:
10089841
8.

The appropriate evaluation of the patient at risk for sudden death from ventricular arrhythmias.

Green MS, Ricci J, Wolfe K.

Can J Cardiol. 2000 Jun;16 Suppl C:13C-5C. Review. No abstract available.

PMID:
10887271
9.

Sudden death in patients with myocardial infarction.

Khera A, Levine BD.

N Engl J Med. 2005 Sep 22;353(12):1294-7; author reply 1294-7. No abstract available.

PMID:
16180270
10.

Sudden death in patients with myocardial infarction.

Zijlstra F, van der Horst IC.

N Engl J Med. 2005 Sep 22;353(12):1294-7; author reply 1294-7. No abstract available.

PMID:
16180271
11.

Relation of body mass index to sudden cardiac death and the benefit of implantable cardioverter-defibrillator in patients with left ventricular dysfunction after healing of myocardial infarction.

Choy B, Hansen E, Moss AJ, McNitt S, Zareba W, Goldenberg I; Multicenter Automatic Defibrillator Implantation Trial-II Investigators.

Am J Cardiol. 2010 Mar 1;105(5):581-6. doi: 10.1016/j.amjcard.2009.10.041. Epub 2010 Jan 22.

PMID:
20185000
12.

Sudden death after myocardial infarction--who needs prophylaxis, and when?

Buxton AE.

N Engl J Med. 2005 Jun 23;352(25):2638-40. No abstract available.

PMID:
15972871
13.

QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study.

Piccirillo G, Magrì D, Matera S, Magnanti M, Torrini A, Pasquazzi E, Schifano E, Velitti S, Marigliano V, Quaglione R, Barillà F.

Eur Heart J. 2007 Jun;28(11):1344-50. Epub 2006 Nov 13.

PMID:
17101636
14.

Effect of antithrombotic therapy on risk of sudden coronary death in patients with congestive heart failure.

Dries DL, Domanski MJ, Waclawiw MA, Gersh BJ.

Am J Cardiol. 1997 Apr 1;79(7):909-13.

PMID:
9104905
15.

Sudden death in patients with myocardial infarction.

Jacobs AG.

N Engl J Med. 2005 Sep 22;353(12):1294-7; author reply 1294-7. No abstract available.

PMID:
16180269
16.

Mechanisms underlying the lack of effect of implantable cardioverter-defibrillator therapy on mortality in high-risk patients with recent myocardial infarction: insights from the Defibrillation in Acute Myocardial Infarction Trial (DINAMIT).

Dorian P, Hohnloser SH, Thorpe KE, Roberts RS, Kuck KH, Gent M, Connolly SJ.

Circulation. 2010 Dec 21;122(25):2645-52. doi: 10.1161/CIRCULATIONAHA.109.924225. Epub 2010 Dec 6.

17.

Effect of ramipril in reducing sudden deaths and nonfatal cardiac arrests in high-risk individuals without heart failure or left ventricular dysfunction.

Teo KK, Mitchell LB, Pogue J, Bosch J, Dagenais G, Yusuf S; HOPE Investigators.

Circulation. 2004 Sep 14;110(11):1413-7. Epub 2004 Sep 7.

19.

Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population).

Zareba W, Piotrowicz K, McNitt S, Moss AJ; MADIT II Investigators.

Am J Cardiol. 2005 Jun 15;95(12):1487-91.

PMID:
15950580
20.

Supplemental Content

Support Center